T-1399 Tofacitinib, Citrate Salt, >99%

Synonyms : [CP-690550] [CP-690550 Citrate] [Tasocitinib]

Related Terms : [Xeljanz]

Prices_reduced
  • Size
  • US $
  • £
  • ¥
  • 25 mg
  • 49
  • 45
  • 38
  • 7,400
  • Add to Cart Qty:
  • In stock
  • 50 mg
  • 71
  • 65
  • 56
  • 10,800
  • Add to Cart Qty:
  • In stock
  • 100 mg
  • 92
  • 84
  • 73
  • 14,000
  • Add to Cart Qty:
  • In stock
  • 200 mg
  • 141
  • 129
  • 111
  • 21,400
  • Add to Cart Qty:
  • In stock
  • 500 mg
  • 225
  • 207
  • 178
  • 34,100
  • Add to Cart Qty:
  • In stock
  • 1 g
  • 337
  • 310
  • 267
  • 51,100
  • Add to Cart Qty:
  • In stock
  • 2 g
  • 566
  • 521
  • 449
  • 85,900
  • Add to Cart Qty:
  • In stock
  • 5 g
  • 995
  • 916
  • 790
  • 151,000
  • Add to Cart Qty:
  • In stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Formal Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Free Shipping and Handling to the U.S. and 32 Other Countries
  • M.W. 504.49
  • C16H20N6O•C6H8O7
  • [540737-29-9]
  • M.I. 14: 10489

Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO at 100 mg/mL; very poorly soluble in ethanol; soluble in water at 6 mg/mL with warming; buffers, serum, or other additives may increase or decrease the aqueous solubility. Disposal: A.

Select Lot Number to view Certificate of Analysis

View the SDS for this product

  • More than 250 labs worldwide have purchased Tofacitinib or its salt forms from LC Labs (either directly from us or from our many distributors, many of whom resell under their own labels).
  • This is the citrate salt form of tofacitinib. See Tofacitinib, Free Base (Cat. No. T-1377) for further technical information. It is this citrate salt form, not the free base, that is used in the formulation of tofacitinib for in vivo use.
  • Tofacitinib citrate is the active ingredient in the drug product sold under the trade name Xeljanz®. This drug is currently approved in at least one country for use in patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. THE TOFACITINIB, CITRATE SALT SOLD BY LC LABORATORIES  FOR RESEARCH IS NOT XELJANZ®, AND IS NOT FOR HUMAN USE.
  • Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
  • This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
  • Not available in some countries; not available to some institutions; not available for some uses.
  • Please see also our other standard immunosuppressant products:
    A-1040 Ascomycin
    C-6000 Cyclosporin A
    E-4040 Everolimus
    F-4633 Fingolimod Hydrochloride Salt
    F-4900 FK-506
    R-5000 Rapamycin
    T-8040 Temsirolimus
    T-1377 Tofacitinib, Free Base
69